Bal Pharma Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.129x

Bal Pharma Limited cash flow conversion efficiency. Based on the latest financial reports, Bal Pharma Limited (BALPHARMA) has a cash flow conversion efficiency ratio of 0.129x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs101.16 Million ≈ $1.09 Million USD) by net assets (Rs783.30 Million ≈ $8.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Bal Pharma Limited (2006–2026)

Cash flow conversion efficiency of Bal Pharma Limited from 2006 to 2026. This chart illustrates how Bal Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bal Pharma Limited stock quote for real-time trading data and today's change.

Bal Pharma Limited Cash Flow Conversion Ratio Explained

Bal Pharma Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bal Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bal Pharma Limited ranked by their cash flow conversion efficiency. Also see market value of Bal Pharma Limited for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Castor Maritime Inc NASDAQ:CTRM	0.011x
GigaMedia Limited F:GIFN	N/A
Daesung Microbiological Labs. Co. Ltd KQ:036480	0.027x
Orbital Corporation Ltd AU:OEC	0.024x
Toleranzia AB ST:TOL	-0.023x
Auking Mining Ltd AU:AKN	-0.199x
Picard Medical, Inc. NYSE MKT:PMI	-1.155x
Vertice Bhd KLSE:7240	0.051x

Annual Cash Flow Conversion Efficiency for Bal Pharma Limited (2006–2026)

The table below shows the annual cash flow conversion efficiency of Bal Pharma Limited from 2006 to 2026. Review Bal Pharma Limited free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs822.52 Million ≈ $8.90 Million	Rs144.72 Million ≈ $1.57 Million	0.176x	+221.79%
2025-03-31	Rs774.04 Million ≈ $8.37 Million	Rs42.32 Million ≈ $457.70K	0.055x	-83.39%
2024-03-31	Rs692.61 Million ≈ $7.49 Million	Rs228.06 Million ≈ $2.47 Million	0.329x	+1237.80%
2023-03-31	Rs637.02 Million ≈ $6.89 Million	Rs-18.43 Million ≈ $-199.37K	-0.029x	-106.11%
2022-03-31	Rs584.92 Million ≈ $6.33 Million	Rs277.08 Million ≈ $3.00 Million	0.474x	+16.04%
2021-03-31	Rs533.54 Million ≈ $5.77 Million	Rs217.81 Million ≈ $2.36 Million	0.408x	-19.88%
2020-03-31	Rs453.38 Million ≈ $4.90 Million	Rs231.01 Million ≈ $2.50 Million	0.510x	+295.55%
2019-03-31	Rs602.21 Million ≈ $6.51 Million	Rs77.58 Million ≈ $838.95K	0.129x	+1663.52%
2018-03-31	Rs602.01 Million ≈ $6.51 Million	Rs-4.96 Million ≈ $-53.64K	-0.008x	-108.44%
2017-03-31	Rs600.31 Million ≈ $6.49 Million	Rs58.58 Million ≈ $633.56K	0.098x	+127.59%
2016-03-31	Rs547.22 Million ≈ $5.92 Million	Rs-193.53 Million ≈ $-2.09 Million	-0.354x	-234.25%
2015-03-31	Rs551.68 Million ≈ $5.97 Million	Rs145.33 Million ≈ $1.57 Million	0.263x	-0.97%
2014-03-31	Rs500.50 Million ≈ $5.41 Million	Rs133.13 Million ≈ $1.44 Million	0.266x	-27.36%
2013-03-31	Rs446.18 Million ≈ $4.83 Million	Rs163.39 Million ≈ $1.77 Million	0.366x	+14.07%
2012-03-31	Rs400.56 Million ≈ $4.33 Million	Rs128.58 Million ≈ $1.39 Million	0.321x	+151.97%
2011-03-31	Rs361.75 Million ≈ $3.91 Million	Rs46.09 Million ≈ $498.42K	0.127x	+187.92%
2010-03-31	Rs357.62 Million ≈ $3.87 Million	Rs-51.82 Million ≈ $-560.40K	-0.145x	-142.27%
2009-03-31	Rs372.35 Million ≈ $4.03 Million	Rs127.64 Million ≈ $1.38 Million	0.343x	+32.33%
2008-03-31	Rs350.32 Million ≈ $3.79 Million	Rs90.75 Million ≈ $981.39K	0.259x	+67.86%
2007-03-31	Rs334.02 Million ≈ $3.61 Million	Rs51.55 Million ≈ $557.46K	0.154x	+183.48%
2006-03-31	Rs323.02 Million ≈ $3.49 Million	Rs-59.71 Million ≈ $-645.75K	-0.185x	--

About Bal Pharma Limited

NSE:BALPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$13.91 Million

Rs1.29 Billion INR

Market Cap Rank

#26057 Global

#1443 in India

Share Price

Rs80.81

Change (1 day)

-1.27%

52-Week Range

Rs60.42 - Rs114.45

All Time High

Rs151.23